A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes

NCT03952143 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

628

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: LY900014
DRUG: Insulin Lispro
DRUG: Insulin Glargine
DRUG: Insulin Degludec

Sponsor

Eli Lilly and Company